Itron, Inc. (NASDAQ:ITRI) Given Average Rating of “Moderate Buy” by Brokerages

Itron, Inc. (NASDAQ:ITRIGet Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $139.00.

A number of research firms recently commented on ITRI. Wall Street Zen raised shares of Itron from a “hold” rating to a “buy” rating in a research report on Saturday, November 1st. Argus restated a “hold” rating on shares of Itron in a research note on Tuesday, November 4th. Oppenheimer set a $145.00 target price on Itron and gave the stock an “outperform” rating in a research report on Friday, October 31st. Zacks Research cut Itron from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 12th. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of Itron in a research note on Monday.

View Our Latest Report on Itron

Insiders Place Their Bets

In related news, CFO Joan S. Hooper sold 948 shares of the firm’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $91,491.48. Following the transaction, the chief financial officer owned 87,446 shares of the company’s stock, valued at $8,439,413.46. This trade represents a 1.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Donald L. Reeves III sold 536 shares of the firm’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $51,729.36. Following the transaction, the senior vice president directly owned 19,068 shares in the company, valued at approximately $1,840,252.68. This represents a 2.73% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 2,971 shares of company stock worth $286,731. Corporate insiders own 1.45% of the company’s stock.

Institutional Trading of Itron

Large investors have recently made changes to their positions in the stock. PNC Financial Services Group Inc. raised its stake in Itron by 10.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,153 shares of the scientific and technical instruments company’s stock valued at $645,000 after purchasing an additional 566 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Itron by 216.3% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 59,503 shares of the scientific and technical instruments company’s stock worth $6,234,000 after buying an additional 40,693 shares in the last quarter. Benjamin Edwards Inc. acquired a new position in shares of Itron in the first quarter valued at approximately $281,000. Invesco Ltd. lifted its stake in shares of Itron by 2.7% during the first quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company’s stock valued at $242,076,000 after buying an additional 59,962 shares during the period. Finally, Aigen Investment Management LP acquired a new stake in Itron during the first quarter worth approximately $311,000. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron Stock Up 1.9%

Itron stock opened at $98.29 on Thursday. The stock has a market cap of $4.50 billion, a PE ratio of 17.68, a P/E/G ratio of 0.47 and a beta of 1.52. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.17 and a quick ratio of 1.91. The stock’s fifty day moving average is $112.23 and its two-hundred day moving average is $121.18. Itron has a 1-year low of $90.11 and a 1-year high of $142.00.

Itron (NASDAQ:ITRIGet Free Report) last released its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.06. The business had revenue of $581.63 million for the quarter, compared to the consensus estimate of $578.49 million. Itron had a return on equity of 17.82% and a net margin of 10.69%.The business’s revenue for the quarter was down 5.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.84 EPS. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. On average, sell-side analysts expect that Itron will post 5.33 EPS for the current fiscal year.

About Itron

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Recommended Stories

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.